http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015106717-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1f4bac45c39a680cd7b15686caea07e4
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D237-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D237-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-501
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-14
filingDate 2015-01-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_740b80ccd57d997ef02b19c47f18e0fb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9cd4c36f9fb269702babc13c627b6741
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bc2ab0364eecba9e216e1c8dbdb31f61
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dded2a0643f2529880893b4b5e31c736
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4674ea17bf18f93d10a28f1e34ed5c7d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b392e1be896ee87ff33a6e21adf536ed
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fa00c93b47ed92033cabed32900f9528
publicationDate 2015-07-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2015106717-A1
titleOfInvention Pyridazinone derivatives, preparation method and use therefor
abstract Disclosed are pyridazinone derivatives as represented by formula (I) or pharmaceutically acceptable salts thereof or hydrates thereof. The present invention provides a series of pyridazinone derivatives that are easily synthesized and have excellent anti-tumor effects. The invention further provides a preparation method and use for said pyridazinone derivatives.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10208024-B2
priorityDate 2014-01-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103772352-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102133217-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009114993-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20120109877-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012085001-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102325766-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID244961375
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11582
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID326576109
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127377127
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID324708363
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID325942074
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68153
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13220559
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID323141705
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID123530346
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128019133
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135953432

Total number of triples: 44.